ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 205.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $166,000 | -20.2% | 47,800 | -46.9% | 0.00% | -50.0% |
| Q4 2018 | $208,000 | +477.8% | 90,100 | +663.6% | 0.00% | – |
| Q1 2016 | $36,000 | -98.0% | 11,800 | -97.5% | 0.00% | -100.0% |
| Q4 2015 | $1,810,000 | +132.9% | 470,197 | +520.5% | 0.01% | +42.9% |
| Q2 2014 | $777,000 | -43.2% | 75,781 | -33.5% | 0.01% | -46.2% |
| Q1 2014 | $1,369,000 | -19.3% | 113,977 | -24.0% | 0.01% | +18.2% |
| Q4 2013 | $1,697,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |